Welcome to ASGCT and Viralgen Vector Core.
Viralgen is gene therapy CDMO, specializing in AAV therapeutics production, created to help broaden the access to life-saving therapeutics and contribute to the advancement of health and human welfare around the world. Through our proprietary Pro10™ suspension manufacturing platform, we deliver industry-leading titers and quality for all AAV serotypes to our client partners, optimizing speed to market and cost-of-goods to accelerate clinical development and commercialization.